Home > Newsletters > RxTrials Institute Drug Pipeline Alert > Exelgen Partners With European Biotech Companies
RxTrials Institute Drug Pipeline Alert
Jan. 2, 2008 | Vol. 6 No. 1
Exelgen Partners With European Biotech Companies
Exelgen, a subsidiary of Commonwealth Biotechnologies, will collaborate with two European-based biotechnology companies.
Both companies have declined to be identified or to disclose contract values at this time.
The partnerships encompass a range of collaborative research activities including medicinal chemistry and application of Exelgen’s LeadHopping technology to identify and progress lead compound series into preclinical studies, according to Commonwealth Biotechnologies.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.